User profiles for "author:Julia F Simard"

Julia F Simard

Associate Professor of Epidemiology & Population Health, and Immunology & …
Verified email at stanford.edu
Cited by 8415

Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies

M Holmqvist, JF Simard, K Asplund, EV Arkema - RMD open, 2015 - rmdopen.bmj.com
Previous studies of stroke in systemic lupus erythematosus (SLE) have had limited statistical
power, combined stroke subtypes into composite outcomes, and lacked a reference …

[HTML][HTML] The representation of gender and race/ethnic groups in randomized clinical trials of individuals with systemic lupus erythematosus

T Falasinnu, Y Chaichian, MB Bass… - Current rheumatology …, 2018 - Springer
Abstract Purpose of Review This review evaluated gender and race/ethnic representation in
randomized controlled trials (RCTs) of patients with systemic lupus erythematosus (SLE) …

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

SE Sattui, JW Liew, K Kennedy, E Sirotich… - RMD open, 2021 - rmdopen.bmj.com
Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …

Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden

M Neovius, JF Simard, J Askling… - Annals of the …, 2011 - ard.bmj.com
Objective To provide Swedish nationwide data on the prevalence of rheumatoid arthritis
(RA), including variations by age, sex, geography, demography and education level, and …

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist

ER Graef, JW Liew, MS Putman, JF Simard… - Annals of the …, 2020 - ard.bmj.com
As of the end of March 2020, the COVID-19 pandemic has resulted in over 850 000
confirmed cases and an estimated 42 000 deaths worldwide. 1 All agree that safe and …

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden

P Raaschou, JF Simard, M Holmqvist, J Askling - Bmj, 2013 - bmj.com
Objectives To investigate the potential association between tumour necrosis factor (TNF)
inhibitor treatment and malignant melanomas in rheumatoid arthritis, melanoma risks in …

Incidence of rheumatoid arthritis in Sweden: a nationwide population‐based assessment of incidence, its determinants, and treatment penetration

JK Eriksson, M Neovius, S Ernestam… - Arthritis care & …, 2013 - Wiley Online Library
Objective To estimate the nationwide incidence of rheumatoid arthritis (RA) in Sweden,
including its variation across age, sex, geography, and demography, and to describe the …

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis

A Finckh, JF Simard, C Gabay, PA Guerne - Annals of the rheumatic …, 2006 - ard.bmj.com
Background: Acquired drug resistance or gradual drug failure has been described with most
disease modifying antirheumatic drugs (DMARDs) and is also starting to be recognised with …

[HTML][HTML] Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study

JT Gustafsson, JF Simard, I Gunnarsson, K Elvin… - Arthritis research & …, 2012 - Springer
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
Cardiovascular disease (CVD) is common and a major cause of mortality. Studies on …

US public concerns about the COVID-19 pandemic from results of a survey given via social media

LM Nelson, JF Simard, A Oluyomi, V Nava… - JAMA internal …, 2020 - jamanetwork.com
Discussion| Using MEPS data, we found that spending on inpatient services, specialty care,
and prescriptions combined accounted for about two-thirds of the increase in total US health …